Abstract:Currently, topical glucocorticosteroids are the most frequently used class of drugs in dermatological practice. Over the years, research has focused on strategies to optimize the delivery vehicle to maximize clinical efficacy while minimizing any associated adverse effects. Recently, a novel topical delivery vehicle, thermolabile foam, has been developed. Two foam-based topical corticosteroid products (betamethasone 17-valerate foam and clobetasol propionate foam) have been approved by FDA for treatment of dermatoses. During the development of these two products, in vitro skin penetration, a vasoconstrictor assay and randomized clinical efficacy study were conducted. Objectives: To compare results of the foam-based clobetasol propionate (0.05%) and another commercially available clobetasol product (clobetasol propionate solution, 0.05%) in the in vitro assay, vasoconstrictor assay and clinical efficacy, and to define the correlation of three commonly used assays. Methods: During the development process, three sets of results were collected. (1) Preclinically, an in vitro flow through system was used to profile the rate of drug penetrating into skin membrane (expressed as peak flux, ng/cm2/hr). (2) A vasoconstrictor assay to determine steroid potency was conducted in 24 healthy subjects in a randomized fashion at a single center. The blanching effects of steroid were monitored by using a chromameter at various timepoints post-application and the maximum skin color change from the baseline was presented as Emax. (3) Clinical efficacy was evaluated in a randomized trial of 188 adult patients with moderate to severe scalp psoriasis treated with a clobetasol product (foam or solution) for 14 days. Investigator’s Global Assessment (IGA) was used, and the percentage of patients to attain completely clear or almost clear (IGA 0 or 1) was presented. Results: Clobetasol Propionate Foam: Preclinical Peak Flux (ng/cm2/hr) = 16.90, Vasoconstrictor Assay (Emax) = −1.15, Clinical Efficacy (% Patients∗) = 74%. Clobetasol Propionate Solution: Preclinical Peak Flux (ng/cm2/hr) = 8.56, Vasoconstrictor Assay (Emax) = −.71, Clinical Efficacy (% Patients∗) = 63%. ∗With completely clear or almost clear. Conclusion: The results showed that foam-based clobetasol has higher skin penetration, more potent vasoconstriction and higher clinical efficacy response rate when compared to clobetasol solution. Thus, it suggests that in vitro skin penetration could be a very useful assay for evaluating novel formulations of topical corticosteroids.

Preparation and Quality Control of Clobetasol Propionate Gel

Preparation and Determination of Compound Ciprofloxacin Suppository

Preparation and Quality Control of Hydrocortisone Enema

Preparation and Quality Control of Mometasone Furoate Gel

Preparation and Quality Control of Compound Ornidazole Gel

Preparation and Quality Control of Progesterone Cream

The preparation and study on the quality control of the ketoconazole ti ncture

Preparation and Quality Evaluation of Compound Bifonazole Nanoemulsion

Quality Control of Vitamin E and Glycyrrhetate Creams

Study on Composition and Preparation Procedure and Quality Control of Vaginal Sustained-Release Progesterone Gel

Study on Preparation and Quality Control of Dexibuprofen Cream

Preparation and Quality Control of Cotrimoxazole Injection

Quality Control of Tacrolimus Ophthalmic Emulsion

Study on the quality control of Baojingsong Hydrogels

Preparation and quality control of compound fusidic acid ophthalmic emulsion

Preparation and Quality Control of Compound Spironolactone Cream

Directional association of preclinical, vasoconstrictor assay and clinical results of topical clobetasol formulations 1 , *1

Preparation and Quality Control of Taste-masked Cefprozil Dry Suspension

Quality by design driven systematic development of nanoemulgel of clobetasol-17-propionate for effective treatment of psoriasis

Study on the preparation and quality control of compound dexamethasone liniment

Study on the Preparation of Tinidazole Compound Gel and its Quality Controlled